ID27987A - Komposisi-komposisi peroral levosimendan pelepasan terkontrol - Google Patents

Komposisi-komposisi peroral levosimendan pelepasan terkontrol

Info

Publication number
ID27987A
ID27987A IDW20002367A ID20002367A ID27987A ID 27987 A ID27987 A ID 27987A ID W20002367 A IDW20002367 A ID W20002367A ID 20002367 A ID20002367 A ID 20002367A ID 27987 A ID27987 A ID 27987A
Authority
ID
Indonesia
Prior art keywords
control
levosiment
personal compositions
personal
compositions
Prior art date
Application number
IDW20002367A
Other languages
English (en)
Indonesian (id)
Inventor
Ilkka Larma
Maarit Harjula
Saila Antila
Lasse Lehtonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27987(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of ID27987A publication Critical patent/ID27987A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
IDW20002367A 1998-04-23 1999-04-23 Komposisi-komposisi peroral levosimendan pelepasan terkontrol ID27987A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980901A FI980901A7 (fi) 1998-04-23 1998-04-23 Levosimendaania säädellysti vapauttavia oraalisia koostumuksia

Publications (1)

Publication Number Publication Date
ID27987A true ID27987A (id) 2001-05-03

Family

ID=8551575

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002367A ID27987A (id) 1998-04-23 1999-04-23 Komposisi-komposisi peroral levosimendan pelepasan terkontrol

Country Status (37)

Country Link
US (1) US7045147B1 (enExample)
EP (1) EP1071397B1 (enExample)
JP (2) JP4566402B2 (enExample)
KR (1) KR100960597B1 (enExample)
CN (1) CN1248691C (enExample)
AR (1) AR019096A1 (enExample)
AT (1) ATE258425T1 (enExample)
AU (1) AU756641B2 (enExample)
BG (1) BG64839B1 (enExample)
BR (1) BR9909869A (enExample)
CA (1) CA2329234C (enExample)
CO (1) CO5070607A1 (enExample)
CZ (1) CZ295194B6 (enExample)
DE (1) DE69914472T2 (enExample)
DK (1) DK1071397T3 (enExample)
EA (1) EA002829B1 (enExample)
EE (1) EE04220B1 (enExample)
ES (1) ES2215379T3 (enExample)
FI (1) FI980901A7 (enExample)
GE (1) GEP20032906B (enExample)
HR (1) HRP20000704B1 (enExample)
HU (1) HUP0101458A3 (enExample)
ID (1) ID27987A (enExample)
IL (2) IL138951A0 (enExample)
MX (1) MXPA00010367A (enExample)
NO (1) NO329809B1 (enExample)
NZ (1) NZ507453A (enExample)
PL (1) PL197447B1 (enExample)
PT (1) PT1071397E (enExample)
RS (1) RS49962B (enExample)
SI (1) SI1071397T1 (enExample)
SK (1) SK285427B6 (enExample)
TR (1) TR200003102T2 (enExample)
TW (1) TWI224507B (enExample)
UA (1) UA68376C2 (enExample)
WO (1) WO1999055305A2 (enExample)
ZA (1) ZA200005632B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
WO2004082615A2 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
FI20070521A7 (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
EP2306823A4 (en) 2008-06-30 2012-09-26 Tocagen Inc 5-FLUOROCYTOSINE FORMULATIONS AND USES THEREOF
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ203684A (en) 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A7 (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578L (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia

Also Published As

Publication number Publication date
EP1071397B1 (en) 2004-01-28
GEP20032906B (en) 2003-02-25
HK1034032A1 (en) 2001-10-12
SK285427B6 (sk) 2007-01-04
CA2329234C (en) 2008-06-10
EE200000617A (et) 2002-06-17
UA68376C2 (en) 2004-08-16
HUP0101458A2 (hu) 2002-03-28
JP2002512946A (ja) 2002-05-08
CN1248691C (zh) 2006-04-05
DK1071397T3 (da) 2004-04-05
KR20010071172A (ko) 2001-07-28
US7045147B1 (en) 2006-05-16
IL138951A (en) 2006-10-31
DE69914472D1 (de) 2004-03-04
CN1301163A (zh) 2001-06-27
CA2329234A1 (en) 1999-11-04
BG104959A (en) 2001-07-31
HUP0101458A3 (en) 2002-05-28
HRP20000704B1 (hr) 2009-11-30
JP2010083900A (ja) 2010-04-15
ATE258425T1 (de) 2004-02-15
YU63900A (sh) 2003-07-07
AU756641B2 (en) 2003-01-16
RS49962B (sr) 2008-09-29
DE69914472T2 (de) 2004-11-11
PT1071397E (pt) 2004-06-30
NO329809B1 (no) 2010-12-20
AR019096A1 (es) 2001-12-26
SI1071397T1 (en) 2004-06-30
FI980901A7 (fi) 1999-10-24
IL138951A0 (en) 2001-11-25
TR200003102T2 (tr) 2001-02-21
PL197447B1 (pl) 2008-03-31
KR100960597B1 (ko) 2010-06-07
WO1999055305A3 (en) 1999-12-29
NZ507453A (en) 2003-02-28
ZA200005632B (en) 2002-01-14
EP1071397A2 (en) 2001-01-31
CO5070607A1 (es) 2001-08-28
PL344078A1 (en) 2001-09-24
EA002829B1 (ru) 2002-10-31
NO20005313D0 (no) 2000-10-20
BR9909869A (pt) 2000-12-19
MXPA00010367A (es) 2002-06-04
WO1999055305A2 (en) 1999-11-04
TWI224507B (en) 2004-12-01
AU3524699A (en) 1999-11-16
NO20005313L (no) 2000-11-21
SK15542000A3 (sk) 2001-08-06
ES2215379T3 (es) 2004-10-01
HRP20000704A2 (en) 2001-04-30
BG64839B1 (bg) 2006-06-30
CZ295194B6 (cs) 2005-06-15
EE04220B1 (et) 2004-02-16
CZ20003780A3 (en) 2001-05-16
JP4566402B2 (ja) 2010-10-20
FI980901A0 (fi) 1998-04-23
EA200001098A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
DK0974335T3 (da) Kosmetiske vaskesammensætninger og deres anvendelse
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
BR9900685B1 (pt) composição sólida desodorante e utilização cosmética de uma composição sólida.
DE69811357D1 (de) Brausezusammensetzungen sowie trockene brausegranulate
EE9900575A (et) Kinolaadi fosforibosüülitransferaasi ekspressiooni reguleerimine
DE69911065D1 (de) Alkoxyacrylamide photochrome beschichtungszusammensetzung und photochrome gegenstände
PT1108039E (pt) Genes de alongases e suas utilizações
PT945132E (pt) Composicao de ibuprofeno
ATE214590T1 (de) Körperpflegezusammensetzungen
ID20344A (id) Komposisi-komposisi pelepasan yang dikontrol
ID24486A (id) Komposisi-komposisi oral dari levosimendan
DE60123342D1 (de) Persönliches digitales endgerät und ausgabesteuerungssystem
FR2788058B1 (fr) Compositions cosmetiques amincissantes
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20006488D0 (no) Sammensetning og anvendelse
ID26370A (id) Komposisi pengkondisian rambut
DE69836248D1 (de) Wasser- und Ölabweisende Zusammensetzung
FR2781231B1 (fr) Compositions cosmetiques amincissantes
FR2783711B1 (fr) Compositions cosmetiques photoprotectrices et utilisations
FI963975L (fi) Sementtipitoisten koostumuksien juoksevuuden säätö
DK1021156T3 (da) Kosmetiske vaskesammensætninger og deres anvendelse
DE69723468D1 (de) Schweisshemmende und deodorierende zusammensetzungen
EP1087782A4 (en) REGULATION OF TYROSINE HYDROXYLASE
FR2761603B1 (fr) Compositions cosmetiques amincissantes
DE69920591D1 (de) Beschichtungszusammensetzungen und Tinten